Allergic rhinitis is a common condition that affects women during pregnancy and causes them great discomfort at this stage of life. Although there are many medications available to be indicated with the aim of reducing the symptoms so annoying, the doctor must very conscientiously evaluate the drug that causes the control of symptoms and obviously must do this minimizing the potential risks of birth defects. As the population is vulnerable, it is practically impossible to test the use of drugs during pregnancy in the context of clinical research for the consequent occurrence of birth defects. Apart from environmental control that clearly does not carry risks at all, there are many medications available to treat this allergic condition so common that also worsens in patients with rhinitis who become pregnant. It is the duty of the physician who treats these patients carefully to elicit the medication that has more benefits than risks and thus help the pregnant patient to overcome this disease that greatly affects their quality of life.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Scialli A, Lone A. Pregnancy effects of specific medications used to treat asthma and immunological diseases. In: Schatz M, Zeiger RS, Claman HN, editors. Asthma and immunological diseases in pregnancy and early infancy. New York: Marcel Dekker; 1998.
Metzger WJ, Turner E, Patterson R. The safety of immunotherapy during pregnancy. J Allergy Clin Immunol. 1978;61:268.
FDA Announcement: https://www.federalregister.gov/articles/2014/12/04/2014-28241/contentand-format-of-labeling-for-human-prescription-drug-and-biological-products-requirementsfor?source=govdelivery&utm_medium=email&utm_source=govdelivery
Mehta N, Larson L. Pharmacotherapy in pregnancy and lactation. Clin Chest Med. 2011;32:43–52.
• Schatz M, Zeiger RS. Diagnosis and management of rhinitis during pregnancy. Allergy Proc. 1988;9:545. This article highlights the fundamental bases for the diagnosis and treatment of allergic rhinitis during pregnancy
Kircher S, Schatz M, Long L. Variables affecting asthma course during pregnancy. Ann Allergy Asthma Immunol. 2002;89:463.
Somoskövi A, Bártfai Z, Tamási L, et al. Population-based case–control study of allergic rhinitis during pregnancy for birth outcomes. Eur J Obstet Gynecol Reprod Biol. 2007;131:21.
Garavello W, Somigliana E, Acaia B, et al. Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. Int Arch Allergy Immunol. 2010;151:137.
Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope. 2000;110:1189.
Eccles R. Nasal airflow in health and disease. Acta Otolaryngol. 2000;120:580.
Turnbull GL, Rundell OH, Rayburn WF, et al. Managing pregnancy-related nocturnal nasal congestion. The external nasal dilator J Reprod Med. 1996;41:897.
Stroud RH, Wright ST, Calhoun KH. Nocturnal nasal congestion and nasal resistance. Laryngoscope. 1999;109:1450.
Wilson J. Use of sodium cromoglycate during pregnancy. J Pharm Med. 1982;8:45.
Heart N. Lung, and Blood Institute, National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment—2004 update. J Allergy Clin Immunol. 2005;115:34.
•• Bérard A, Sheehy O, Kurzinger ML, Juhaeri J. Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes. J Allergy Clin Immunol. 2016;138:97. This article shows the risk of using triamcinolone, a widely used intranasal corticosteroid in a pregnant patient
•• Namazy JA, Schatz M. The safety of intranasal steroids during pregnancy: a good start. J Allergy Clin Immunol. 2016;138:105. This article shows the safety level of most of intranasal corticosteroids available
Källén B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med. 2002;11:146.
Schatz M, Petitti D. Antihistamines and pregnancy. Ann Allergy Asthma Immunol. 1997;78:157.
Yau WP, Mitchell AA, Lin KJ, et al. Use of decongestants during pregnancy and the risk of birth defects. Am J Epidemiol. 2013;178:198.
Rayburn WF, Anderson JC, Smith CV, et al. Uterine and fetal Doppler flow changes from a single dose of a long-acting intranasal decongestant. Obstet Gynecol. 1990;76:180.
Schatz M, Zeiger RS, Falkoff R, et al. Asthma and allergic diseases during pregnancy. In: Adkinson NF, Bochner BS, Burks AW, et al., editors. Middleton's allergy: principles and practice. 7th ed. St. Louis: Mosby; 2014. p. 951.
Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology. 1992;45:361.
Källén BA, Olausson PO. Use of oral decongestants during pregnancy and delivery outcome. Am J Obstet Gynecol. 2006;194:480.
Smith CV, Rayburn WF, Anderson JC, et al. Effect of a single dose of oral pseudoephedrine on uterine and fetal Doppler blood flow. Obstet Gynecol. 1990;76:803.
Cottle MK, Van Petten GR, van Muyden P. Effects of phenylephrine and sodium salicylate on maternal and fetal cardiovascular indices and blood oxygenation in sheep. Am J Obstet Gynecol. 1982;143:170.
Torfs CP, Katz EA, Bateson TF, et al. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology. 1996;54:84.
• Lu Y, Yin M, Cheng L. Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;49(8):659–67. This meta-analysis shows that although antileukotrienes are widely used there is little or no information on their use during pregnancy
Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385.
Dombrowski MP, Schatz M. ACOG Committee on practice bulletins-obstetrics. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy. Obstet Gynecol. 2008;111:457.
Ellegård EK, Karlsson NG, Ellegård LH. Rhinitis in the menstrual cycle, pregnancy, and some endocrine disorders. Clin Allergy Immunol. 2007;19:305.
Ellegård EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol Allied Sci. 2001;26:394.
Conflict of Interest
Dr. Mónica S. De Gennaro declares that she has no conflict of interest. Dr. Fernando S. Serrano declares that he has no conflict of interest. Dr. Jorge F. Máspero declare that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
This article is part of the Topical Collection on Allergic Rhinitis
About this article
Cite this article
De Gennaro, M.S., Serrano, F.S. & Máspero, J.F. Pharmacologic Management of Allergic Rhinitis During Pregnancy. Curr Treat Options Allergy 4, 54–61 (2017). https://doi.org/10.1007/s40521-017-0111-y
- Allergic rhinitis
- Congenital malformations